Substituting Doxorubicin with Nonpegylated Liposomal Doxorubicin for the Treatment of Early Breast Cancer: Results of a Retrospective Study

Introduction. Evidence from the metastatic setting suggests that replacing conventional doxorubicin with nonpegylated liposomal doxorubicin (NPLD) for early breast cancer may maintain efficacy whilst reducing long-term cardiotoxicity, an important consideration with many patients going on to receive...

詳細記述

保存先:
書誌詳細
主要な著者: Davidson, Neville, Camburn, Teresa, Keary, Ian, Houghton, David
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2014
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913086/
https://ncbi.nlm.nih.gov/pubmed/24527216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/984067
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料